Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
JANUMET XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Resolved	2022-03-25	2022-04-12	157337
JANUVIA	100MG	TABLET	Resolved	2017-07-05	2017-07-15	14703
JANUVIA	25MG	TABLET	Avoided shortage	2022-01-31	2022-02-11	153908
JANUVIA	100MG	TABLET	Resolved	2023-01-30	2023-02-22	182687
JANUVIA	100MG	TABLET	Resolved	2023-01-04	2023-01-26	179856
JANUVIA	100MG	TABLET	Resolved	2017-07-17	2017-10-11	15836
PMS-SITAGLIPTIN	50MG	TABLET	Actual shortage	2025-07-04	2025-11-10	261846
PMS-SITAGLIPTIN	100MG	TABLET	Actual shortage	2025-07-04	2025-10-10	261849
SANDOZ SITAGLIPTIN-METFORMIN	1000MG 50MG	TABLET	Resolved	2023-07-17	2023-08-30	198838
SANDOZ SITAGLIPTIN-METFORMIN	500MG 50MG	TABLET	Resolved	2023-08-29	2023-09-26	203193

Previous
1
…
6
7
8
9
10
Next

Showing 71 to 80 of 98

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
JANUMET	850MG 50MG	TABLET	Discontinued	2024-12-12	2025-08-14	245516
STEGLUJAN	5MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133310
STEGLUJAN	15MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133307

1

Showing 1 to 3 of 3